17 studies found for:    uPAR
Show Display Options
Rank Status Study
1 Not yet recruiting uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
Condition: Urinary Bladder Neoplasms
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Drug: Injection of 18F-FDG;   Device: Positron Emission Tomography and CT;   Device: Positron Emission Tomography and MRI
2 Recruiting uPAR PET/CT for Preoperative Staging of Breast Cancer Patients
Condition: Breast Cancer
Interventions: Other: 68Ga-NOTA-AE105;   Device: Positron Emission Tomography PET/CT
3 Terminated Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Abiraterone;   Drug: Prednisolone
4 Completed Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Conditions: Breast Cancer;   Prostate Cancer;   Urinary Bladder Cancer
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Device: Positron Emission Tomography scans
5 Completed Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Conditions: Breast Cancer;   Prostate Cancer;   Urinary Bladder Cancer
Intervention: Other: Injection of 64Cu-DOTA-AE105
6 Recruiting uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung
Conditions: Non-small Cell Lung Cancer;   Malignant Pleural Mesothelioma;   Large Cell Neuroendocrine Carcinoma of the Lung
Intervention: Other: 68Ga-NOTA-AE105 PET/CT
7 Completed Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia
Condition: BPH
Intervention: Procedure: transurethral resection of the prostate
8 Unknown  Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Late-onset Neonatal Sepsis
Condition: Neonatal Sepsis
Intervention:
9 Completed Dietary Seaweed and Early Breast Cancer: A Randomized Trial
Condition: Seaweed Associated Changes in Healthy Subjects
Interventions: Other: Seaweed;   Other: Placebo;   Other: Placebo2
10 Unknown  GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy
Condition: Prostate Cancer
Interventions: Other: Low Dose GTN 0.0285 mg/hr;   Other: High Dose GTN 0.057 mg/hr;   Other: Placebo
11 Unknown  Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma
Conditions: Breast Neoplasms;   Mastectomy
Intervention: Drug: Solu-medrol 125 mg
12 Recruiting A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients
Condition: FSGS
Intervention:
13 Active, not recruiting Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer
Conditions: Prostate Cancer;   Elevated Prostate Specific Antigen (PSA)
Intervention: Other: serum specimens obtained will be utilized for proteomic profiling comprising MALDI-TOF MS, and serum biomarker assays.
14 Recruiting A Crossover Pilot Study of the Effect of Amiloride on Proteinuria
Condition: Proteinuria
Interventions: Drug: Amiloride;   Drug: Triamterene
15 Not yet recruiting Healing Hearts and Mending Minds in Older Adults Living With HIV
Conditions: HIV;   Cardiovascular Disease;   AIDS
Interventions: Behavioral: Let's Move Program;   Behavioral: Let's Flex Program;   Behavioral: Group Motivational Interviewing
16 Recruiting Role of SLURP-1 in Melanoma and Melanoma Stem Cells
Condition: Melanoma;
Intervention:
17 Recruiting Clinical Evaluation of Novel Biomarkers in Patients With Septicemia
Conditions: Sepsis;   Bacteremia;   Fungemia
Intervention:

Indicates status has not been verified in more than two years